Effective date 2024-12-20 Label type HUMAN PRESCRIPTION DRUG LABEL Version 9 Source full-release Hydrated at 2026-05-31 21:19:59 Key Label Information# Uses INDICATIONS AND USAGE Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
A larger group is on the FDA review track but cannot be dispensed until the process completes
Studies show that adequate intake of B12 (along with other B vitamins) can help lower the risk of fractures, especially in older adults
It is not licensed for human consumption or medical use
The arginine salt form is cited in the patents as superior for absorption, though head-to-head clinical data confirming that advantage dont yet exist
